UnitedHealth Group Incorporated (NYSE:UNH) is Stifel Financial Corp’s 9th Largest Position

Stifel Financial Corp trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,668,553 shares of the healthcare conglomerate’s stock after selling 29,964 shares during the period. UnitedHealth Group accounts for about 1.0% of Stifel Financial Corp’s investment portfolio, making the stock its 9th biggest holding. Stifel Financial Corp’s holdings in UnitedHealth Group were worth $975,667,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently bought and sold shares of UNH. BDF Gestion bought a new stake in shares of UnitedHealth Group in the second quarter worth approximately $14,284,000. Manning & Napier Advisors LLC bought a new stake in UnitedHealth Group during the second quarter valued at approximately $161,697,000. OLD National Bancorp IN grew its position in UnitedHealth Group by 5.5% during the second quarter. OLD National Bancorp IN now owns 55,804 shares of the healthcare conglomerate’s stock valued at $28,419,000 after buying an additional 2,925 shares during the period. DHJJ Financial Advisors Ltd. grew its position in UnitedHealth Group by 16.0% during the second quarter. DHJJ Financial Advisors Ltd. now owns 145 shares of the healthcare conglomerate’s stock valued at $74,000 after buying an additional 20 shares during the period. Finally, City Holding Co. lifted its holdings in UnitedHealth Group by 1.8% during the second quarter. City Holding Co. now owns 11,741 shares of the healthcare conglomerate’s stock valued at $5,979,000 after purchasing an additional 208 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 0.9 %

Shares of UNH opened at $610.63 on Thursday. The firm’s fifty day moving average is $587.40 and its two-hundred day moving average is $558.20. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $561.95 billion, a PE ratio of 39.78, a price-to-earnings-growth ratio of 1.78 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.56 EPS. Research analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.38%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Analyst Upgrades and Downgrades

UNH has been the topic of several research analyst reports. Cantor Fitzgerald boosted their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Bank of America decreased their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. UBS Group reduced their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Truist Financial reissued a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $621.58.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.